Author:
Hohberger B.,Stenger N.,Trollmann R.,Mardin C. Y.,Gusek-Schneider G.-C.
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Chen H, Chan AY, Stone DU, Mandal NA (2014) Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders. Surv Ophthalmol 59:64–76
2. Kaback MM, Desnick RJ (2011) Hexosaminidase a deficiency. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K (Hrsg) GeneReviews® (Internet). University of Washington, Seattle, S 1993–2016
3. Nakaya-Onishi M, Suzuki A, Okamoto N, Fukuda M (2000) Observations on time course changes of retinal appearance in a patient with Tay Sachs disease. Br J Ophthalmol 84:1320–1321
4. Ospina LH, Lyons CJ, McCormick AQ (2005) “Cherry-red spot” or “perifoveal white patch”? Can J Ophthalmol 40:609–610
5. Takeda K, Nakai H, Hagiwara H et al (1990) Fine assignment of beta-hexosaminidase A alpha-subunit on 15q23-q24 by high-resolution in situ hybridization. Tohoku J Exp Med 160:203–211